Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113045503B reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and scalable API intermediate manufacturing solutions.
Patent CN113735826B details Pd-catalyzed carbonylation for quinolones. Offers scalable routes and cost reduction in pharma manufacturing with high purity.
Novel Pd-catalyzed carbonylation patent CN115286628B offers high purity intermediates with scalable supply chain advantages for global pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation method offers high yields and substrate tolerance for scalable drug molecule production.
Patent CN115353511A reveals a safe Pd-catalyzed carbonylation method for synthesizing indolinone-imidazole hybrids, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381A reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yield, broad substrate scope, no external oxidant required for efficient pharmaceutical intermediate production.
Novel reductive aminocarbonylation route using nitroarenes offers high yields and simplified purification for complex pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation for indole and benzoxazine intermediates. Delivers cost-effective scalable pharmaceutical solutions with high purity and robust supply chain reliability for global partners.
Patent CN117164506B details a novel palladium-catalyzed carbonylation route for indeno indole ketones, offering significant supply chain and cost advantages for API manufacturing.
Novel nickel-catalyzed carbonylation method for 2-piperidinone derivatives offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN119161318A reveals a novel Pd-catalyzed route for benzopyran amides. Offers sustainable manufacturing, reduced waste, and reliable supply chain solutions for global pharmaceutical intermediates.
Patent CN114195711B reveals Pd-catalyzed carbonylation for quinoline-4(1H)-one. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN115353511A details a safe, one-pot palladium-catalyzed carbonylation method for synthesizing complex biheterocycles, offering significant cost and safety advantages.
Patent CN110028394B details a novel Pd-catalyzed carbonylation for indanones. This method offers cost reduction in API manufacturing and streamlined supply chains.
Patent CN113045489B reveals a novel Pd-catalyzed route to quinolinones using benzisoxazole, offering cost-effective API intermediate manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering high yields and scalable production for reliable pharmaceutical intermediate suppliers.
Novel nickel-catalyzed carbonylation method for indoles. High efficiency, broad substrate scope. Ideal for API intermediates.
Novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones. Enhanced purity, scalable process, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN117164534A enables efficient Pd-catalyzed route. Cost reduction in pharmaceutical intermediates manufacturing. High-purity benzofuran derivatives available.